"Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2013" Published
Global Markets Direct's, 'Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Anaplastic Large Cell Lymphoma (ALCL), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Anaplastic Large Cell Lymphoma (ALCL). Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, Half Year is built using data and information sourced...
View full press release